Advertisement Helix granted patent for peptides used in cosmetics - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Helix granted patent for peptides used in cosmetics

Helix BioMedix, a developer of bioactive peptides, has received US patent that covers more than eighty proprietary peptides for use in cosmetic and skin care applications and products, from the US Patent and Trademark Office.

There are currently over 20 marketed products using peptides protected under the patent including such cosmeceutical brands as Fusion Beauty, Smashbox, Isomers, and B Kamins. Numerous additional product roll outs are planned in 2008.

Stephen Beatty, president and CEO of Helix, said: “While our primary focus is dermatological therapeutic development, this represents our first issued patent specifically targeting cosmetic and skin care applications, which is the direct result of our efforts to diversify our sequences as well as their bioactivities and application.”